Answers are grounded in this paper and cite their sources.
This editorial highlights critical methodological flaws in the MRC trial of treating hypertension in older adults, including high loss to follow-up and poor adherence, questioning the validity of its subgroup findings.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Anna Mitchell (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: